GHRP-2 vs GHRP-6 Dosing Compared

GHRP-2 and GHRP-6 are both hexapeptide agonists of the same ghrelin/growth-hormone-secretagogue receptor (GHS-R1a), dosed in micrograms — but they are not interchangeable: GHRP-2 is the stronger growth-hormone releaser per microgram, while GHRP-6 provokes markedly more hunger. Crucially, the number of syringe units you draw for a given microgram dose is identical for both, because units follow the vial concentration, not which peptide is in it. Neither is FDA-approved, so every figure below is arithmetic, not a recommended dose.

TL;DR — key takeaways

• Same receptor, different balance. Both bind GHS-R1a. GHRP-2 favours GH release; GHRP-6 favours the ghrelin-like appetite signal.
• GHRP-2 is more potent for GH. Per microgram it drives a larger GH pulse, so research protocols often use smaller amounts of it than of GHRP-6.
• GHRP-6 makes you hungry. Intense hunger within minutes is its signature side effect; GHRP-2's appetite effect is present but milder.
• The units are the same. 100 mcg of GHRP-2 and 100 mcg of GHRP-6 from the same-strength vial are the same number of units — the peptide name never enters the maths.
• Both are investigational. No regulator has set a dose, purity, or potency standard for either. This page is maths, not medical advice.

What they are, and why the receptor is shared

Both peptides are synthetic growth-hormone-releasing peptides (GHRPs) that predate the discovery of the body's own version of the signal. GHRP-6 (His-DTrp-Ala-Trp-DPhe-Lys-NH₂) was the first, described by Bowers and colleagues in 1984 as a hexapeptide that selectively released GH without touching LH, FSH, TSH, or prolactin at standard amounts. GHRP-2 (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) followed as a more potent analogue. Both act at the growth-hormone-secretagogue receptor (GHS-R1a), the receptor cloned in 1996 and later shown to be the target of the stomach hormone ghrelin, identified in 1999. Both are, in effect, ghrelin mimetics found before ghrelin itself.

Because they act at a receptor rather than being replaced dose-for-dose like testosterone, the active amounts are tiny — hundreds of micrograms, not milligrams. A 5 mg vial holds 5,000 mcg, which is why the draws land in single digits on a U-100 insulin syringe. Both have short plasma half-lives on the order of half an hour, so they are studied as pulsatile, split-through-the-day peptides rather than once-weekly ones.

Where the two actually differ

The receptor is the same; the downstream balance is not. GHRP-2 raises the GH pulse more strongly per microgram and carries a moderate appetite effect. GHRP-6 is the hunger peptide — its ghrelin-like drive to eat is pronounced — and at matched amounts it tends to nudge cortisol and prolactin somewhat. Neither profile makes one "better"; the choice in a research setting turns on whether the appetite signal is wanted or avoided.

Human data anchor the potency point: in an early controlled study the GHRP-6-type hexapeptide produced dose-dependent GH release in healthy men, with clear responses from about 0.25 mcg/kg upward — and GHRP-2 is reported to be the stronger of the two on a per-microgram basis.

Relative profile, visualised

An illustrative sketch of how the two split the same receptor's effects. Bars are relative, not measured ratios — they show direction, not exact magnitude.

Reconstitution and unit math — identical for both

This is the part that surprises people: the drug name never appears in the calculation. Both peptides arrive as a lyophilised (freeze-dried) powder in a 5 mg or 10 mg vial, and you make either injectable by adding bacteriostatic water. The water you add sets the concentration, and the concentration sets the units:

• Concentration = milligrams in the vial ÷ millilitres of water added.
• Draw volume = dose ÷ concentration (work in mcg throughout).
• Units = draw volume in mL × 100, because a U-100 syringe reads 100 units per 1 mL.

The painless shortcut is mcg per unit: one unit is 0.01 mL, so each unit carries (concentration in mcg/mL ÷ 100) micrograms. Work that out once and every dose is a single division — and it is the same number whether the vial is labelled GHRP-2 or GHRP-6.

Dose-to-units reference chart

Units on a U-100 syringe for common example doses, at two concentrations. The two peptides share one column because the units do not depend on which one you drew. These are arithmetic illustrations, not recommendations — confirm against your own vial label.

Read down a single column once your mix is set; the whole column scales linearly with the dose. A stronger mix pushes every draw into low single digits, where a one-unit misread is a bigger percentage error — a common reason to choose a gentler concentration for microgram peptides.

How this is calculated

Every figure here rests on two facts and no drug-specific constant: a U-100 syringe holds 100 units per mL, and concentration is milligrams divided by the millilitres of water you add. Convert your dose to the same unit as the concentration, divide to get millilitres, and multiply by 100 for units — or use the mcg-per-unit shortcut and divide once. Because the arithmetic ignores the molecule, GHRP-2 and GHRP-6 draw identically. The reconstitution calculator automates this so you can cross-check against the chart above. None of this is medical advice.

Safety and honest caveats

Neither GHRP-2 nor GHRP-6 is approved by the FDA or any comparable regulator for human use. They are sold for research, so no authority has verified a safe dose, and compounded vials are not held to the purity or potency standards approved drugs must meet. Growth-hormone secretagogues are not benign: they can raise IGF-1 and affect blood glucose, GHRP-6 in particular drives strong hunger, and long-term effects are not established. Treat every microgram figure here as arithmetic, handle any injectable only under a qualified clinician's direction, store the reconstituted vial refrigerated, and never map an amount of one peptide onto the other by feel — their potencies differ.

Frequently asked questions

Do I draw more units for GHRP-6 than GHRP-2?

No. For the same microgram dose from the same-strength vial the units are identical — the maths never sees the peptide name. What differs is the effect per microgram, so the two are often used at different microgram amounts even though a given amount draws the same way.

Which one causes more hunger?

GHRP-6. Its ghrelin-like appetite drive is pronounced and can appear within minutes. GHRP-2 also stimulates appetite but more mildly, which is one reason it is sometimes preferred when the hunger effect is unwanted.

Can I mix GHRP-2 and GHRP-6 in one vial?

Blending peptides is a technique question with real purity and dosing-accuracy pitfalls, and there is no approved protocol for it. If two peptides are combined, the units for each still come from that vial's concentration — but this should only be done under qualified guidance, not by guesswork.

Are GHRP-2 and GHRP-6 approved medicines?

No. Both are investigational research peptides with no FDA approval for any use. Human evidence is limited to early studies, and no regulator has set a standard dose, purity, or potency for either.

Related guides

• Ipamorelin dosing and reconstitution explained
• CJC-1295 vs ipamorelin: dosing and units
• Why peptides are measured in micrograms
• How much bacteriostatic water should I add?
• All guides

Skip the arithmetic and let the peptide reconstitution calculator do the mixing math for you.